Abiopharma

OKTA, INC. (OKTA)

Symbol	OKTA
Name	OKTA, INC.
Sector	TECHNOLOGY
Region	North America
Industry	Computer Software: Prepackaged Software
Address	100 FIRST STREET,SUITE 600, SAN FRANCISCO, California, 94105, United States
Telephone	+1 888 722-7871
Fax	—
Email	—
Website	https://www.okta.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001660134
Description	Okta sells solutions for identity and access management. Its workforce offerings contain products to protect and enable employees, contractors, and partners, while customer identity and access products securely enable an organizations customers to use applications. Oktas software solutions are cloud-delivered, and its integration network gives customers security protection and access across a wide variety of applications that are critical to business and government needs. The California-based company went public in 2017. Additional info from NASDAQ: Okta sells solutions for identity and access management. Its workforce offerings contain products to protect and enable employees, contractors, and partners, while customer identity and access products securely enable an organizations customers to use applications. Oktas software solutions are cloud-delivered, and its integration network gives customers security protection and access across a wide variety of applications that are critical to business and government needs. The California-based company went public in 2017.

2026-06-24 21:04

Schwartz Larissa 🔴 sold 69.3K shares (3 derivative) of Okta, Inc. (OKTA) at $120.00 Transaction Date: Jun 22, 2026 | Filing ID: 000011

2026-06-24 19:19

📋 Shellye Archambeau (Director) plans to sell 9K shares of Okta Inc. (at $119.05 each, total $1.1M) Filed: Jun 24, 2026 | ID: 000721

2026-06-23 21:05

(99% Neutral) OKTA, INC. (OKTA) Announces Executive Changes

2026-06-23 20:58

Kelleher Eric Robert 🔴 sold 145.5K shares (6 derivative) of Okta, Inc. (OKTA) at $274.96 ($6.2M) Transaction Date: Jun 18, 2026 | Filing ID: 000007

2026-06-22 22:51

Director Schellhase David 🟢 acquired 2.1K shares (1 derivative) of Okta, Inc. (OKTA) Transaction Date: Jun 18, 2026 | Filing ID: 000003

2026-06-22 22:49

Director SAGAN PAUL 🟢 acquired 2.1K shares (1 derivative) of Okta, Inc. (OKTA) Transaction Date: Jun 18, 2026 | Filing ID: 044758

2026-06-22 22:48

Director BERNSHTEYN ROBERT 🟢 acquired 2.1K shares (1 derivative) of Okta, Inc. (OKTA) Transaction Date: Jun 18, 2026 | Filing ID: 044757

2026-06-22 22:34

Director Kerrest Jacques Frederic 🟡 adjusted position in 1.4M shares (9 derivative) of Okta, Inc. (OKTA) at $274.96 ($27.2M) Transaction Date: Jun 18, 2026 | Filing ID: 000003

2026-06-22 22:33

Director Epstein Jeff 🟡 adjusted position in 0 shares (1 derivative) of Okta, Inc. (OKTA) Transaction Date: Jun 17, 2026 | Filing ID: 000005

2026-06-22 22:32

Director Dixon Robert L JR 🟡 adjusted position in 0 shares (1 derivative) of Okta, Inc. (OKTA) Transaction Date: Jun 17, 2026 | Filing ID: 000005